Subject: Important Regulatory Update: Testing Availability for MGM-15, SR-17018, and Mitragynine Pseudoindoxyl
—
1. The Federal Regulatory Status (Clarification)
-
July 6, 2026 (Notice of Intent): The U.S. Drug Enforcement Administration (DEA) published a formal Notice of Intent (Docket No. DEA-1570) proposing the temporary placement of these synthetic and semi-synthetic derivatives into federal Schedule I.
-
July 31, 2026 (Comment Window Close): July 31 was the administrative closing date for the Department of Health and Human Services (HHS) public comment period on the docket. It was an administrative comment deadline, not an enforcement date or final ban.
-
Current Federal Status: As of today, the DEA Administrator has not published a final Temporary Scheduling Order in the Federal Register. Therefore, these compounds are not yet listed on the explicit Federal Controlled Substances Act Schedule I table.
TESTING STATUS: Because explicit federal Schedule I placement has not taken effect, analytical laboratory testing for these analytes remains fully authorized under federal law. Wonderland-Labs is actively accepting and providing quantitative testing for MGM-15, SR-17018, and Mitragynine Pseudoindoxyl.
—
2. Important State-Level Exception: Florida Emergency Regulations
While federal scheduling remains pending, state-level regulations operate independently.
Clients manufacturing, distributing, or shipping samples within or through Florida must take note of active emergency actions:
-
Florida Emergency Rules: The Florida Attorney General and state health officials have issued emergency rules designating highly concentrated 7-OH, MGM-15, Mitragynine Pseudoindoxyl, and related semi-synthetic alkaloid derivatives as Schedule I controlled substances under Florida state law.
-
State Compliance & Transport: While our analytical testing facilities remain federally authorized, clients in Florida—or those transporting samples through Florida—must ensure compliance with state-level controlled substance laws and FDACS food safety concentration limits.
—
How We Are Handling Sample Submissions
-
Active Testing: Wonderland-Labs continues to provide full quantitative testing and COAs for MGM-15, SR-17018, and Mitragynine Pseudoindoxyl for clients operating in compliant jurisdictions.
-
State Compliance Verification: We strongly encourage all clients to review local state laws (specifically in Florida and other emergency-rule jurisdictions) before submitting samples or distributing products containing these compounds.
-
Daily Monitoring: We monitor the Federal Register Public Inspection queue daily. If the DEA formally publishes a final federal Temporary Scheduling Order, we will notify you immediately regarding any necessary adjustments to sample acceptance policies.
BOTTOM LINE: NOTHING HAS CHANGED ON A FEDERAL LEVEL YET IN RELATION TO 7OH, MGM-15, SR-17018 OR MITRAGYNINE PSEUDOINDOXYL. WONDERLAND LABS IS STILL TESTING AS USUAL, AND HAVE NEW COA’S TO REFLECT THE POTENTIAL FEDERAL RULING AS WELL AS FLORIDA’S RECENT EMERGENCY SCHEDULING.
HELPFUL LINKS: